References
- Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik S D. Long-term survival following bacteremia or fungemia. JAMA 1995; 274: 807–812
- Weinstein M P, Reller L B, Murphy J R, Lichtenstein K A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5: 35–53
- Gatell J M, Trilla A, Latorre X, Almela M, Mensa J, Moreno A, Miro J M, Martinez J A, Jimenez de Anta M T, Soriano E, Garcia S, an Miguel J. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev Infect Dis 1988; 10: 203–210
- Leibovici L, Konisberger H, Pitlik S D, Samra Z, Drucker M. Bacteremia and fungemia of unknown origin in adults. Clin Infect Dis 1992; 14: 436–443
- Aube H, Milan C, Blettery B. Risk-factors for septic shock in the early management of bacteremia. Am J Med 1992; 93: 283–288
- Rackow E C, Astiz M E. Pathophysiology and treatment of septic shock. JAMA 1991; 266: 548–554
- Warren H S, Danner R L, Munford R S. Anti-endotoxin monoclonal antibodies. N Engl J Med 1992; 326: 1153–1157
- Cross A S. Anti-endotoxin antibodies: a dead end?. Ann Intern Med 1994; 121: 58–60
- Natanson C. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771–783
- Wolff S. Biological effects of bacterial endotoxins in man. J Infect Dis 1973; 128: S259–S64
- Suffredini A, Fromm R, Parker M, Brenner M, Kovacs J A, Wesley R A, Parrilo J E. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280–286
- Bone R C. Gram-positive organisms and sepsis. Arch Intern Med 1994; 154: 26–34
- Bamberger D M, Gurley M B. Microbiological etiology and clinical characteristics of distributive shock. Clin Infect Dis 1994; 18: 726–730
- Bone R C. Why sepsis trials fail. JAMA 1996; 276: 565–566
- The LOGISTIC procedure. In: SAS/STAT User's Guide, version 6, 4th edition. SAS Institute Inc., Cary, NC 1990; vol. 2: 1071–1126
- Leibovici L, Greenshtain S, Cohen O, Mor F, Wysenbeek A J. Bacteremia in febrile patients: a clinical model for diagnosis. Arch Intern Med 1991; 151: 1801–1806
- Pompei P, Charlson M E, Ales K, MacKenzie C R, Norton M. Relating patients characteristics at the time of admission to outcomes of hospitalization. J Clin Epidemiol 1991; 44: 1063–1069
- Corti M-C, Guralnik J M, Salive M E, Sorkin J D. Serum albumin level and physical disability as predictors of mortality in older patients. JAMA 1994; 272: 1036–1042
- Deysine M, Liwblich N, Aufsen H A. Albumin changes during clinical septic shock. Surg Gynecol Obstet 1973; 173: 474–478
- Holcroft J W, Trunkey D D, Carpenter M A. Extravasation of albumin in tissues of normal and septic baboons and sheep. J Surg Res 1979; 26: 341–347
- Phillips A, Shaper A G, Whincup P H. Association between serum albumin and mortality from cardiovascular disease. cancer and other causes. Lancet 1989; 2: 1434–1436
- Weinstein M P, Murphy J R, Reller L B, Lichtenstein K A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983; 5: 54–70
- Leibovici L, Pitlik S D, Konisberger H, Drucker M. Bloodstream infections in patients older than eighty years. Age Ageing, 22: 431–442